Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thorough QT/QTc Study of Gadopiclenol in Healthy Volunteers
NCT03657264Phase 1Completed
- Sponsor
- Guerbet
- Start
- Aug 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of gadopiclenol (4 arms), sponsored by Guerbet. Primary endpoint: Change-from-baseline Mean Effect of P03277 on QT Interval Expressed as QTc According to Fridericia's Formula at 24 hours. Started Aug 2017; status: completed.
02
Drugs
gadopiclenol
Beyond the preview
Go deeper on NCT03657264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03657264.